TNFSF10 and Hepatic fibrosis: Cells such as erythrocytes, macrophages and cancer cells have been explored widely for biomimetic NP-based drug delivery applications.10 As an example, Xia et al. recently developed biomimetic NPs coated with hepatic stellate cell (HSC) membranes presenting tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) for liver fibrosis therapy.